{"entity":{"type":"insider","cik":"0001316420","url":"/insider/0001316420","json_url":"/insider/0001316420.json","name":"Ahn Chang Ho","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":7,"first":"2008-04-15","last":"2017-04-12","span_basis":"filed_date"},"name_variants":[{"name":"Ahn Chang Ho","source":"filing","n_filings":7,"first_seen":"2008-04-15","last_seen":"2017-04-12"}],"transactions":[{"id":4671403,"accession":"0001140361-17-015713","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-015713","line_url":"/filing/0001140361-17-015713#line-2","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":0.7015,"price_display":"0.70","price_state":"stated","total_value":175375.0,"total_display":"175,375.00","total_whole":"175,375","shares_owned_after":6010000.0,"shares_owned_after_display":"6,010,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-10","filed_date":"2017-04-12","scope":"insider"},{"id":8246309,"accession":"0001140361-15-001481","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-15-001481","line_url":"/filing/0001140361-15-001481#line-6","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48444.0,"shares_display":"48,444","price_per_share":0.9137,"price_display":"0.91","price_state":"stated","total_value":44263.2828,"total_display":"44,263.28","total_whole":"44,263","shares_owned_after":6010000.0,"shares_owned_after_display":"6,010,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-12","scope":"insider"},{"id":8246302,"accession":"0001140361-15-001481","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-15-001481","line_url":"/filing/0001140361-15-001481#line-4","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":186212.0,"shares_display":"186,212","price_per_share":0.9155,"price_display":"0.92","price_state":"stated","total_value":170477.086,"total_display":"170,477.09","total_whole":"170,477","shares_owned_after":6010000.0,"shares_owned_after_display":"6,010,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-09","filed_date":"2015-01-12","scope":"insider"},{"id":8246297,"accession":"0001140361-15-001481","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-001481","line_url":"/filing/0001140361-15-001481#line-2","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":0.9004,"price_display":"0.90","price_state":"stated","total_value":72032.0,"total_display":"72,032.00","total_whole":"72,032","shares_owned_after":6010000.0,"shares_owned_after_display":"6,010,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":6403306,"accession":"0001140361-14-025828","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-14-025828","line_url":"/filing/0001140361-14-025828#line-2","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136193.0,"shares_display":"136,193","price_per_share":0.9871,"price_display":"0.99","price_state":"stated","total_value":134436.1103,"total_display":"134,436.11","total_whole":"134,436","shares_owned_after":6813924.0,"shares_owned_after_display":"6,813,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-12","filed_date":"2014-06-16","scope":"insider"},{"id":9168978,"accession":"0001140361-11-029093","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-029093","line_url":"/filing/0001140361-11-029093#line-1","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1008078.0,"shares_display":"1,008,078","price_per_share":1.31,"price_display":"1.31","price_state":"stated","total_value":1320582.18,"total_display":"1,320,582.18","total_whole":"1,320,582","shares_owned_after":11338924.0,"shares_owned_after_display":"11,338,924","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-05-18","filed_date":"2011-05-20","scope":"insider"},{"id":9012851,"accession":"0001140361-11-020856","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-11-020856","line_url":"/filing/0001140361-11-020856#line-1","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":320846.0,"shares_display":"320,846","price_per_share":1.22,"price_display":"1.22","price_state":"stated","total_value":391432.12,"total_display":"391,432.12","total_whole":"391,432","shares_owned_after":10330846.0,"shares_owned_after_display":"10,330,846","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-01","filed_date":"2011-04-05","scope":"insider"},{"id":5709109,"accession":"0001140361-09-010936","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-09-010936","line_url":"/filing/0001140361-09-010936#line-3","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2600000.0,"shares_display":"2,600,000","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":1768000.0,"total_display":"1,768,000.00","total_whole":"1,768,000","shares_owned_after":10260000.0,"shares_owned_after_display":"10,260,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-04","filed_date":"2009-05-04","scope":"insider"},{"id":5709108,"accession":"0001140361-09-010936","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-09-010936","line_url":"/filing/0001140361-09-010936#line-2","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":260000.0,"shares_display":"260,000","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":176800.0,"total_display":"176,800.00","total_whole":"176,800","shares_owned_after":10520000.0,"shares_owned_after_display":"10,520,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-05-04","filed_date":"2009-05-04","scope":"insider"},{"id":3444282,"accession":"0001140361-08-009589","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001140361-08-009589","line_url":"/filing/0001140361-08-009589","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RXHN.OB","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001316420","owner_name":"Ahn Chang Ho","owner_display_name":"Ahn Chang Ho","owner_url":"/insider/0001316420","role":"Director, Officer (Chairman & CEO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.398,"price_display":"2.40","price_state":"stated","total_value":23980.0,"total_display":"23,980.00","total_whole":"23,980","shares_owned_after":14009500.0,"shares_owned_after_display":"14,009,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-04-14","filed_date":"2008-04-15","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001228627","name":"REXAHN PHARMACEUTICALS, INC.","url":"/issuer/0001228627","role":"Director, Officer (Chairman & CEO), Ten percent owner","n_filings":7,"first_seen":"2008-04-15","last_seen":"2017-04-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001316420","retrieved_at":"2026-08-25T18:43:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}